Showing results (81-90 of 248) with videos related to

Sort By:
Pageof 25
The Oncologist|December 16, 2018
Direct-Acting Antivirals in Hepatitis C Virus-Associated Diffuse Large B-cell LymphomasMichele Merli, Marco Frigeni, Laurent Alric, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 28, 2005
Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision makingLuca Malcovati, Matteo Giovanni Della Porta, Cristiana Pascutto, et al.
Cytotherapy|September 10, 2025
Overcoming barriers to referral for CAR T-cell therapy in patients with non-Hodgkin aggressive B-cell lymphomas: A Delphi consensusStefano Luminari, Annalisa Chiappella, Alice Di Rocco, et al.
The American Journal of Medicine|November 16, 2004
Life expectancy and prognostic factors for survival in patients with polycythemia vera and essential thrombocythemiaFrancesco Passamonti, Elisa Rumi, Ester Pungolino, et al.
Hematological Oncology|April 23, 2022
B-cell activating factor (BAFF), BAFF promoter and BAFF receptor allelic variants in hepatitis C virus related Cryoglobulinemic Vasculitis and Non-Hodgkin's LymphomaLaura Gragnani, Serena Lorini, Silvia Marri, et al.
Haematologica|September 16, 2008
Prognostic factors for thrombosis, myelofibrosis, and leukemia in essential thrombocythemia: a study of 605 patientsFrancesco Passamonti, Elisa Rumi, Luca Arcaini, et al.
Ejhaem|December 18, 2024
Interleukin-6 transcripts up-regulation in lymph nodes from unicentric and multicentric Castleman diseaseMarco Lucioni, Gaia Morello, Caterina Cristinelli, et al.
Microorganisms|June 15, 2023
Gut Microbiota and B Cell Receptor (BCR) Inhibitors for the Treatment of Chronic Lymphocytic Leukemia: Is Biodiversity Correlated with Clinical Response or Immune-Related Adverse Event Occurrence? A Cross-Sectional StudyValentina Zuccaro, Greta Petazzoni, Irene Mileto, et al.
Hematological Oncology|April 25, 2024
Real-life study on the use of response adapted therapy in patients with Hodgkin Lymphoma: Results from a multicenter experienceVittorio Ruggero Zilioli, Emanuele Cencini, Sonya De Lorenzo, et al.
Human Pathology|February 6, 2021
Double expressor and double/triple hit status among primary cutaneous diffuse large B-cell lymphoma: a comparison between leg type and not otherwise specified subtypesMarco Lucioni, Carlo Pescia, Arturo Bonometti, et al.
Pageof 25